References
- WHO Cancer. Available at: http://www.who.int/hpr/NPH/docs/gs_cancer.pdf, http://www.who.int/diet physical activity/publications/facts/cancer/en/
- Menta E, Palumbo M. Novel antineoplastic agents. Exp Opin Ther Patents 1997;7:1401–1426.
- Liu KK, Li J, Sakya S. Synthetic approaches to the 2003 new drugs. Mini Rev Med Chem 2004;4:1105–1125.
- Powis G, Hacker MP, eds. (1991). The toxicity of anticancer drugs. New York: Pergamon Press, 106–151.
- Siripong P, Hahnvajanawong C, Yahuafai J, Piyaviriyakul S, Kanokmedhakul K, Kongkathip N et al. Induction of apoptosis by rhinacanthone isolated from Rhinacanthus nasutus roots in human cervical carcinoma cells. Biol Pharm Bull 2009;32:1251–1260.
- Pardee AB, Li YZ, Li CJ. Cancer therapy with beta-lapachone. Curr Cancer Drug Targets 2002;2:227–242.
- Wang D, Xia M, Cui Z, Tashiro S, Onodera S, Ikejima T. Cytotoxic effects of mansonone E and F isolated from Ulmus pumila. Biol Pharm Bull 2004;27:1025–1030.
- Saha DK, Padhye S, Sinn E, Newton C. Synthesis, structure, spectroscopy and antitumor activity of hydroxynaphthoquinone thiosemicarbazone and its metal complexes against MCF-7 human breast cancer cell line. Ind J Chem 2002;41A:279–283.
- Kongkathip N, Kongkathip B, Siripong P, Sangma C, Luangkamin S, Niyomdecha M et al. Potent antitumor activity of synthetic 1,2-Naphthoquinones and 1,4-Naphthoquinones. Bioorg Med Chem 2003;11:3179–3191.
- Gokhale N, Padhye S, Newton C, Pritchard R. Hydroxynaphthoquinone metal complexes as antitumor agents x: synthesis, structure, spectroscopy and in vitro antitumor activity of 3-methyl-phenylazo lawsone derivatives and their metal complexes against human breast cancer cell line mcf-7. Met Based Drugs 2000;7:121–128.
- Afrasiabi Z, Sinn E, Chen J, Ma Y, Rheingold AL, Zakharov LN et al. Appended 1,2-naphthoquinones as anticancer agents 1: synthesis, structural, spectral and antitumor activities of ortho-naphthaquinone thiosemicarbazone and its transition metal complexes. Inorg Chim Acta 2004;357:271–278.
- Chen J, Huang YW, Liu G, Afrasiabi Z, Sinn E, Padhye S et al. The cytotoxicity and mechanisms of 1,2-naphthoquinone thiosemicarbazone and its metal derivatives against MCF-7 human breast cancer cells. Toxicol Appl Pharmacol 2004;197:40–48.
- Shukla S, Srivastava RS, Shrivastava SK, Sodhi A, Kumar P. Synthesis, characterization and antiproliferative activity of 1,2-naphthoquinone and its derivatives. Appl Biochem Biotechnol 2012 167:1430–1445.
- Halinska A, Belej T, O’Brien PJ. Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts. Br J Cancer Suppl 1996;27:S23–S27.
- Frydman B, Marton LJ, Sun JS, Neder K, Witiak DT, Liu AA et al. Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones. Cancer Res 1997;57:620–627.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
- Sengupta D, Verma D, Naik PK. Docking mode of delvardine and its analogues into the p66 domain of HIV-1 reverse transcriptase: screening using molecular mechanics-generalized born/surface area and absorption, distribution, metabolism and excretion properties. J Biosci 2007;32:1307–1316.
- Zheng XG, Kang JS, Kim Y, You YJ, Jin GZ, Ahn BZ. Glutathione conjugates of 2- or 6-substituted 5,8-dimethoxy-1,4-naphthoquinone derivatives: formation and structure. Arch Pharm Res 1999;22:384–390.
- Priebe W, Krawczyk M, Kuo MT, Yamane Y, Savaraj N, Ishikawa T. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem Biophys Res Commun 1998;247:859–863.
- Pallas 3.1.1.2, ADME-Tox software. CompuDrug International Inc., U.S.A., 2000.